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 A comprehensive classiﬁcation of lymphatic-system malformation in primary lymphoedema is proposed and may lead to further
study of the aetiology as well as rational treatment of the disease.a r t i c l e i n f o
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Objectives: The study aims to investigate lymphatic-system malformations and proposes a classiﬁcation
of primary lymphoedema based on comprehensive imaging data of both lymph vessel- and lymph-node
abnormalities.
Materials and methods: A total of 378 patients with primary lymphoedema of the lower extremity were
examined with magnetic resonance lymphangiography (MRL) using gadobenate dimeglumine as
contrast agent. Lymph vessels and drainage lymph nodes were evaluated, leading to the proposal of the
classiﬁcation of primary lymphoedema and the relative proportions.
Results: A total of 63 (17%) patients exhibited defects of the inguinal lymph nodes with mild or moderate
dilatation of afferent lymph vessels. A total of 123 (32%) patients exhibited lymphatic anomalies as
lymphatic aplasia, hypoplasia or hyperplasia with no obvious defect of the drainage lymph nodes. The
involvement of both lymph vessel- and lymph-node abnormalities in the affected limb was found in 192
(51%) patients. The primary lymphoedema was classiﬁed as three major types as: (1) lymph nodes
affected only; (2) lymph vessel affected only with three subtypes and (3) both lymph vessel and lymph
node affected with subgroups.
Conclusions: A comprehensive classiﬁcation of lymphatic-system malformation in primary lymphoedema
is proposed, which clearly deﬁnes the location and pathologic characteristics of both lymphatics and
lymph node and may lead to further study of the aetiology as well as rational treatment of the disease.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Primary lymphoedema is deﬁned as oedema caused by
lymphatic dysplasia and/or dysfunction due to congenital1,2 or
unknown factors. Primary lymphoedema occurs in 1 of every
10,000 people in the general population.3 Patients with primary
lymphoedema exhibit diverse clinical signs.4 The disorder most
commonly affects one lower extremity. Management of the indi-
vidual patient has been hampered by difﬁculties in understanding
the complex underlying pathophysiology and determining the
prognosis. Kinmonth classiﬁed primary lymphoedema: (1) by the4; fax: þ86 21 53078025.
ciety for Vascular Surgery. Publisheage at the time of onset; under this classiﬁcation, the congenital
type is relatively rare and presents at birth, while praecox is a more
common type, developing during puberty, and the tarda type
occurs after the age of 35 years and (2) by the abnormality of
lymphatic vessels including aplasia, hypoplasia, hyperplasia and
lymph-node ﬁbrosis.5 However, Kinmonth’s classiﬁcation is based
on direct lymphangiography excluding patients for whom
lymphatic cannulation is not possible. Furthermore, direct lymph-
angiography is limited to imaging part of the superﬁcial lymphatic
territory instead of mapping the entire lymphatic system. Kin-
month noted lymph-node abnormalities such as ﬁbrosis in primary
lymphoedema. However, X-ray imaging cannot clearly delineate
nodal pathology.d by Elsevier Ltd. All rights reserved.
Figure 1. Composition images of MR lymphangiogram shows various lymphatic
drainage pathways in primary lymphoedematous limbs. (a) A few weaker enhanced
lymphatic vessels (arrowhead) in the inner side of lower limb of healthy volunteer. (b)
Enhanced lymph vessels with cystic dilatation (arrowhead) in the distal part of the leg.
(c) Numerous aberrant tortuous vessels with a mixture of larger (arrow) and smaller
vessels (arrowhead). (d) A crisscross network of hyperplastic vessels in the thigh
(arrow) and the calf (arrowhead). (e) Single deep lymph vessel (arrowhead) and
popliteal nodes (arrow) were enhanced with absence of superﬁcial lymph vessel. (f)
Both superﬁcial lymphatics (arrowhead) and deep lymph vessels and popliteal nodes
(arrow) were involved. (g) Numerous hyperplasic lymph vessels with regular fold
throughout the limb. (h) Treelike varicose lymph vessels in the calf (arrowhead) and
channels with regular fold in the thigh (arrow).
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study of lymphatic disease. Magnetic resonance lymphangiography
(MRL) has emerged as a powerful imaging technique for the diag-
nosis of lymphatic disorders.6e10Dynamic and real-time observa-
tion of contrast enhancement in lymphatic vessels and drainage
nodes with high-resolution images can provide comprehensive
information concerning both the structural and functional abnor-
malities of the lymphatic system in primary lymphoedema and
lymphoedema-related disease.7 Intracutaneously injected para-
magnetic contrast material was found to be easily absorbed by
initial lymph vessels. As such, all patients including those with
lymphatic aplasia were examined and included in the present
study. We conducted repeated MRL examinations evaluating some
patients twice or more to follow treatment outcomes and the
course of the disease. Compared with commonly used lympho-
scintigraphy techniques, MRL is more sensitive and accurate for
outlining the morphological and structural changes to the
lymphatic channel and lymph node.11 In the current study, 378
patients with primary lymphoedema of the leg were examined
using MRL. The lymph collectors and drainage nodes were studied
as a whole system. The MRL data revealed lymphatic-system
abnormalities that were more complex than those described in
any previous report.3e5 The current article summarises imaging
results from 378 patients, and proposes a comprehensive classiﬁ-
cation system for lymphatic-system malformations in primary
lymphoedema.
Materials and Methods
The present study included 378 patients diagnosed with
primary lymphoedema (180 men and 198 women with a mean age
of 33 years; range 5e77 years). Patients who had experienced
adenolymphangitis, injury, tumour, radiotherapy or surgery before
the onset of oedemawere not included in the study. Of the selected
patients, 297 exhibited unilateral lymphoedema, and 81 exhibited
bilateral primary lymphoedema in lower extremities. The mean
duration of disease across all patients was 12 years, ranging from 4
months to 55 years. Seven patients exhibited true congenital
familial lymphoedema.
MRL was performed as described previously,7,8 using a 3.0 T MR
unit (Philips Medical System, Best, the Netherlands). First, three-
dimensional (3D) heavily T2-weighted magnetic resonance
imaging (MRI) was performed. After injection of the paramagnetic
contrast agent gadobenate dimeglumine (Gd-BOPTA) into digital
web spaces (0.7e0.8 ml/each point; MultiHance; Bracco, Milan,
Italy), 3D fast spoiled gradient-recalled echo T1-weighted images
were acquired using a fat-saturation technique at consecutive time
points for dynamic observation, Six consecutive inspections were
performed in the leg, with each inspection taking 3 min. Five
consecutive inspections were performed in the inguinal region and
thigh each taking 3 min. Maximum intensity projection (MIP)
reconstruction imaging was performed to map lymphatic vessels.
Imaging of regional lymph nodes was acquired before and after
contrast injection. The enhancement of contrast in regional lymph
nodes was recorded and measured as the ratio of nodal/muscle
signal intensity for direct comparison between bilateral inguinal
lymph nodes. The lymph collectors and their drainage nodes were
treated as a whole system in the analysis and classiﬁcation of
imaging data from primary lymphoedema limbs.
Results
After intracutaneous injection, the contrast was rapidly absor-
bed by the primary lymph vessels and transported with the lymph.
The enhancement of lymphatic vessels and lymph nodes wasinspected during the dynamic MRL and the drainage patterns of
lymphatic vessels and nodes were clearly observed. Importantly, no
enhanced lymph vessels were visualised in most contralateral
healthy limbs. In some non-oedema limbs, weaker enhanced
lymphatic channels were observed (Fig. 1(a)) and inguinal nodes
were enhanced rapidly and completely (Fig. 2). Changes of the
lymphatic system in primary lymphoedema can occur in the lymph
vessels, the nodes, or both. The MRL ﬁndings regarding the lymph
vessel- and lymph-node anomalies in 378 primary lymphoedema
cases are summarised in Table 1.Lymphatic anomalies
The number of lymphatic vessels ranged from 0 to numerous,
and the diameter ranged from 0.5 to 8 mm in lymphoedematous
limbs. The classiﬁcation of lymphatic abnormality was determined
mainly on the basis of the number and shape of the vessels. In cases
of aplasia/hypoplasia, the peripheral vessels were either absent or
severely hypoplastic in terms of number and size. In cases of
Figure 2. Diverse inguinal nodes abnormalities of primary lymphoedema displayed on MR Lymphangiogrames. (a). Imaging of inguinal lymph nodes (arrowhead) in healthy
volunteer that were evenly enhanced and symmetry in shape and arrangement. (b) Single small node in a limb (arrow) with lymphatic hypoplasia and lymphoedema is compared
with lymph nodes in a limb without lymphoedema. (c) Partially contrast-enhanced inferior inguinal nodes (arrow) in bilateral lymphoedema with secondary lymphatic dilatation.
(d) Central part enhanced inferior inguinal node (arrow) compared with evenly enhanced contralateral healthy nodes. (e) Small nodes that are irregular shaped (small arrow) in
a limb with lymphangiectasia (large arrow). (f) Enlarged inguinal lymph nodes (arrow) with homogeneous texture in the left side in contrast with lymph nodes of normal size in the
right side.
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and dilated, and were observed in the limb and trunk. A total of 209
patients were diagnosed with lymphatic aplasia/hypoplasia. No
superﬁcial lymphatic trunks were visualised in the affected limbs ofTable 1




Lymph node anomalies 272 (72%)
Lymph node affected only with nodal structural abnormal 63
Lymph node structural abnormal with lymphatic
hypoplasia/hyperplasia
105 (77/28)
Lymph node hypoplasia with lymphatic
hypoplasia/hyperplasia
77 (39/38)
Lymph node hyperplasia with lymphatic
hypoplasia/hyperplasia
27 (8/19)
Lymphatic anomalies 315 (83%)
Lymphatic affected only 106
Lymphatic dysplasia with nodal abnormal 209
Lymphatic hypoplasia 209
No visualised superﬁcial vessel 70
A few superﬁcial vessels 121
Deep lymphatic visualised only 18
Lymphatic hyperplasia 106
Superﬁcial vessel affected only 77
Both superﬁcial & deep vessel affected 29
Chylous reﬂux 1670 patients. In 18 patients, only 1e2 deep lymph vessels were
identiﬁed (Fig. 1(b)). A small number of superﬁcial lymph vessels
were visualised in 121 patients. Among these patients, the
enhanced vessels stopped in the distal part (above the ankle) of the
limb in nearly half of the cases (Fig. 1(c)). A total of 106 patients
were diagnosed with lymphatic hyperplasia of the affected limbs,
in which numerous aberrant tortuous vessels were strongly
enhanced. The results revealed considerable variability in the sizes
and distribution patterns of the lymphatic trunks (Fig. 1(d)e(g)).
Both the superﬁcial and deep lymphatic systemwere affected in 29
patients (Fig. 1(h)). Of these patients, 16 exhibited chylous reﬂux.Lymph-node anomalies
Lymph-node abnormalities fell into three major categories,
aplasia/hypoplasia, or hyperplasia or structural abnormalities. The
common pathological features of affected lymph nodes included:
signiﬁcant increases or decreases in size and number (or total
absence), irregular outline, heterogeneous texture and partial
(marginal or central region) contrast enhancement (Fig. 2(b)e(f)). Of
378 patients, 272 showed morphological changes of the inguinal
and/or iliac lymph nodes. Among 272 patients with severely affected
nodes, 120 had never experienced cellulitis or lymphadenitis.
Of 272 patients, 63 exhibited more severely affected nodes than
vessels, with moderate dilatation of the vessel without obvious
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hypoplasia or hyperplasia groups. Interestingly, malformations of
lymphatic vessels were not always concordant with those of the
lymph nodes. Among 77 patients with hypoplasia of the inguinal
lymph nodes of the affected limbs, 38 exhibited hyperplasia of the
efferent lymph vessels. In contrast, among 27 patients with
hyperplasia of the inguinal lymph nodes eight exhibited lymphatic
hypoplasia. The coincidence of hypoplasia of lymphatic vessels and
lymph nodes of the affected limbs was observed in 39 patients.
Evidence of abnormalities in both lymphatic vessels and drainage
lymph nodes, exhibited as hyperplasia, was observed in 19 patients.
The iliac lymph-node abnormalities were commonly seen in the
lymph node and lymphatic hyperplasia groups.
Classiﬁcation of lymphatic-system anomalies
In summary, theMRL ﬁndings of lymphatic-system anomalies in
primary lymphoedema were divided into three major patterns.
Evident defects of the inguinal lymph node with moderate dilata-
tion of afferent lymph vessels were observed in 63 patients (17%).
Lymphatic anomalies, including lymphatic aplasia, hypoplasia or
hyperplasia with no obvious defect of the drainage lymph nodes,
were observed in 106 (28%) patients. Abnormalities of both lymph
vessels and lymph nodes in the affected limbwere exhibited in 209
(55%) cases. Based on these results, we propose the following
classiﬁcation of lymphatic-system abnormalities in primary lym-
phoedema using MRL imaging:
(1) Only lymph nodes affected, with nodal structural abnormalities,
(2) Only lymph vessels affected:
(a) lymphatic aplasia/hypoplasia and
(b) lymphatic hyperplasia
(3) Lymph vessels and lymph nodes affected, with subgroups:
(a) lymphatic and nodal aplasia/hypoplasia,
(b) lymphatic aplasia/hypoplasia þ nodal hyperplasia,
(c) lymphatic aplasia/hypoplasia þ nodal structural abnor-
malities,
(d) lymphatic and nodal hyperplasia,
(e) lymphatic hyperplasia þ nodal aplasia/hypoplasia and
(f) lymphatic hyperplasia þ nodal structural abnormalities.
Clinical data regarding this MRL classiﬁcation are presented in
Table 2.We found no clear difference between groups regarding the
onset time of lymphoedema. The frequency of tarda development
of lymphoedema was 40% (26/63) in the lymph node affected-only
group, followed by 29% (36/124) in the nodal abnormal/lymphatic-
hyperplasia group, 10% (9/85) in the nodal abnormal/lymphatic-Table 2
Clinical data between the MR lymphangiographic classiﬁcations.
Lymph node
affected only





No. of patients 63 85 21 39 8
Male:female (35:28) (31:54) (13:8) (16:23) (3
Congenital 12 21 7 14 2
Praecox 26 57 11 17 4
Tarda 25 6 3 8 2
Unilateral 47 59 18 34 8
Bilateral 16 26 3 6 0
Infection
No 41 45 7 19 4
Few 13 23 7 8 2
Frequent 9 17 7 12 2hypoplasia group and 8% (9/106) in the lymphatic affected-only
group. The tarda type thus appeared to be relatively common in
lymph node-related lymphoedema. There was no signiﬁcant
difference in the severity of disease between the lymphatic/node
hypoplasia and hyperplasia groups. In general, oedema became
more extensive and tissue ﬁbrosis progressed as the course of the
disease progressed in all groups. The seriousness of oedema and
ﬁbrosis appears to be more relevant to the course of the disease
than the type of lymphatic-system malformations involved.
Oedema in the ankle and foot was most common in the lymphatic
hypoplasia-only group. Oedema in the thigh and/or extragenital
sites and/or buttocks and lower abdomenwall were more common
in the inguinal lymph node aplasia/hypoplasia and node affected-
only types.
Discussion
Primary lymphoedema is typically managed as a chronic lym-
phoedema without consideration of its background as a congenital
vascular malformation.12 The present report summarises diverse
lymphatic and lymph-node malformations in 378 patients with
primary lymphoedema based on high-resolution MRL images. The
classiﬁcation proposed in the current report covers three major
types of lymphatic-system malformation in the disease as follows:
only lymph nodes affected, only lymph vessels affected and both
lymph vessels and lymph nodes affected. These types contain
respective subtypes. This updated classiﬁcation system clearly
deﬁnes the location and pathological characteristics of the disease
to provide a clear and more useful deﬁnition. Therefore, the
proposed system is likely to be more convenient and understand-
able for clinical workers and patients, and to facilitate investiga-
tions into the respective aetiologies of the pathological changes in
the vessels and nodes involved in the disease.
The current results revealed that the malformations of lymph
vessels were not always concordant with those of the lymph nodes
in primary lymphoedema. The lymph vessel and node may be
affected together or alone, and may express different types of
anatomical anomalies. The latter category is not included in Kin-
month’s classiﬁcation.5 Some patients with hyperplasia of the
lymphatic vessels of the affected limbs were found to exhibit an
absence of drainage lymph nodes, and somewith hyperplasia of the
inguinal lymph nodes exhibited few afferent lymph vessels. The
diverse morphological anomalies of the lymphatic system, and the
discordance of pathological changes between lymph vessels and
nodes, indicate the complexity of the pathoaetiology of the disease.
Recent studies with newly discovered molecules have revealed that
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14 7 6 3
37 25 13 22
26 6 0 3
51 31 17 23
16 7 2 5
34 18 9 6
18 10 3 9
25 11 7 13
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of primary lymph sacs, the mutual development of the lymphatic
vasculature and the lymph nodes then stops, and both structures
develop independently of each other; (2) lymphatic sprouting and
bloodelymphatic vascular separation; and (3) the remodelling and
maturation of the initial lymphatic-vessel network into lymphatic
capillaries and lymphatic collecting vessels. The heterogeneous
phenotype of lymphatic-system abnormalities in primary lym-
phoedema may result from events occurring at different stages of
embryonic development of the lymphatic system.13,15,16 For
example, hypoplasia of lymph vessels may result from a failure or
lack of endothelial budding. The hyperplasia of both lymphatic
channels and drainage nodes is likely to result from an event
occurring during lymphatic speciﬁcation and budding, or at the
stage of the formation of primary lymph sacs before the separation
of lymphatic vessels and lymph-node development.
In conclusion, the current report proposes a novel classiﬁcation
based on high-resolution MRL that covers three major types of
lymphatic-system malformation in primary lymphoedema. This
new classiﬁcation system may be helpful in further studies
focussed on the development of more appropriate target-oriented
treatment.
MRL is a relatively new approach. We made the comparison of
MRL with lymphoscintigraphy in our previous study;11 the data are
not included in the present report. The reproducibility of MRL in
evaluating lymphatic disorders will further be demonstrated in
a separate paper.Ethical Approval
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Shanghai Science and Technology Committee (grant nos.
09410706400, 10411964100 and 10440711000).Conﬂict of Interest
None.
References
1 Kinmonth JB. The lymphatics, disease, lymphography, and surgery. London:
Arnold; 1982. p. 128e9.
2 Ferrell RE, Levinson KL, Esman JH, Kimak MA, Lawrence EC, Barmada MM, et al.
Hereditary lymphedema: evidence for linkage and genetic heterogeneity. Hum
Mol Genet 1998;7:2073e8.
3 Petrek JA, Pressman PI, Smith RA. Lymphedema: current issues in research and
management. CA Cancer J Clin 2000;50(5):292e307.
4 Kinmonth JB, Eustace PW. Lymph nodes and vessels in primary lymphedema.
Ann R Coll Surg Engl 1976;58:274e84.
5 Kinmonth JB, Wolfe JH. Fibrosis in the lymph nodes in primary lymphedema
histological and clinical studies in 74 patients with lower-limb oedema. Ann R
Coll Surg Engl 1980;62:344e54.
6 Pan D, Suzuki Y, Yang PC, Rockson SG. Indirect magnetic resonance lymphan-
giography to assess lymphatic function in experimental murine lymphedema.
Lympha Res Biol 2006;4:211e6.
7 Liu NF, Lu Q, Jiang ZH, Wang CG, Zhou JG. Anatomic and functional evaluation
of the lymphatics and lymph nodes in diagnosis of lymphatic circulation
disorders with contrast magnetic resonance lymphangiography. J Vasc Surg
2009;49:980e7.
8 Lu Q, Xu J, Liu N. Chronic lower extremity lymphedema: a comparative study of
high-resolution interstitial MR lymphangiography and heavily T2-weighted
MRI. Eur J Radiol 2010;73:365e73.
9 Notohamiprodjo M, Baumeister RGH, Jakobs TF, Bauner KU, Boehm HF,
Horng A, et al. MR-lymphangiography at 3.0Tea feasibility study. Eur Radiol
2009;19:2771e8.
10 Kamble RB, Shetty R, Diwakar N, Madhusudan G. Technical note: MRI lymph-
angiography of the lower limb in secondary lymphedema. Indian J of Radogy &
Imaging 2011;21:15e7.
11 Liu NF, Lu Q, Liu PA, Wang BS. Comparison of radionuclide lymphoscintigraphy
and dynamic magnetic resonance lymphangiography for investigating
extremity lymphedema. Br J Surg 2010;97:359e65.
12 Lee BB. Current issue in management of chronic lymphoedema: personal
reﬂection on an experience with 1065 patients. Commentary Lymphology
2005;38:28e31.
13 Oliver G. Lymphatic vasculature development. Nat Rev Immunol 2004;4:35e45.
14 Blum KS, Pabst R. Keystones in lymph node development. J Anat 2006;209:
585e95.
15 Cueni LN, Detmar M. The lymphatic system in health and disease. Lymphat Res
Biol 2008;6:109e22.
16 Harvey NL. Embryonic lymphatic development: recent advances and unan-
swered questions. Lymphat Res Biol 2005;3:157e65.
